Peter Young

Peter is a life-science industry consultant with over 35 years’ experience in the pharmaceutical and biotech industry, spanning all areas of the business from sales representative to country-level general manager at multinationals like Abbott and Glaxo as well as biotech start-ups. In the mid-1990s, he led the global introduction of combination HIV therapy for Glaxo Wellcome while keying industry leadership on global treatment access. 

Currently, Peter serves as a venture partner with Pappas Capital leading the firm’s initiatives in translational medicine and is the Program Manager for Wake Forest Baptist Medical Center’s Technology Development Program. He also serves as an Executive in Residence at Cold Spring Harbor Laboratories and the Center for Biotechnology at Stony Brook University. He is a member of the Oversight Committee for the University of Miami Wallace H. Coulter Center for Translational Research, the Long Island Bioscience Hub External Review Board and the Long Island Biomentor Initiative, a past member of the BIO board and chairman of the North Carolina Biosciences Organization, and was a director of Memory Pharmaceuticals from 2004 until its sale to Roche in 2009. 

• Biopharma:  Drug Delivery; Therapeutics; Vaccines 
• Therapeutics: Cardiovascular; Dermatology; Diabetes, Metabolism, Endocrinology & Obesity; Ear, Nose & Throat; Emergency Medicine; Gastroenterology & Digestive Disease; Immunology, Autoimmune & Inflammation; Infectious Diseases; Nephrology – Renal; Neurodegenerative; Oncology; Psychiatry; Regenerative Medicine – Tissue Engineering; Respiratory & Pulmonary; Urology 
• Biomedical-Other: Precision Health; Public Health; Healthcare Delivery; Biodefense 
• Other: Specialty Pharma; Ag Bio and Ag tech; Venture capital, investment and fundraising; Business development and partnering; Pricing and Access policies